论文部分内容阅读
目的 评估雷米普利对各种适应症的效果和安全性,为医院药品购进和管理、临床医生用药提供研究依据,并探讨基于证据进行药物评估的实用方法。方法 采用系统评价和卫生技术评估原则,检索Medline,Cochrane Library及药业公司提供有关资料,全面收集全世界范围内发表的有关雷米普利(Ramipril)的研究文章,对纳入研究逐个进行质量评价,并将所有研究结果进行综合分析。结果 收集到214篇提到雷米普利的文章,符合纳入标准的共18篇,病例数共计31139例。研究内容包括:高血压、糖尿病、心衰、心肌梗塞、肾病、心脑血管病的二级预防。结论 根据现有证据,我们认为此药是一种有效、安全、易使用的药物,值得推广应用。
Objective To evaluate the efficacy and safety of ramipril in various indications, to provide a research basis for the purchase and management of medicines in hospitals, and to provide reference for the use of drugs by clinicians and to explore practical methods for drug evaluation based on evidence. Methods The systematic reviews and the principles of health assessment were used to search for relevant information provided by Medline, the Cochrane Library and pharmaceutical companies. A comprehensive survey of ramipril research articles published worldwide was conducted to assess the quality of studies included , And all the results of a comprehensive analysis. Results A total of 214 essays on ramipril were collected, which met the inclusion criteria of 18 articles in 31,139 cases. Research includes: secondary prevention of hypertension, diabetes, heart failure, myocardial infarction, nephropathy and cardiovascular and cerebrovascular diseases. Conclusion Based on the available evidence, we believe this drug is an effective, safe and easy-to-use drug that is worth promoting.